Travere Therapeutics (TVTX) had the highest return in Q3 2007 by a mid-cap US stock, returning 600%.
| ASSET | QUARTER | % RETURN |
|---|---|---|
Travere Therapeutics (TVTX) | Q3 2007 | 600% |
Archrock (AROC) | Q3 2007 | 454.58% |
Riot Blockchain (RIOT) | Q3 2007 | 109.78% |
Corcept Therapeutics (CORT) | Q3 2007 | 78.83% |
Crocs (CROX) | Q3 2007 | 55.85% |
Cal-Maine Foods (CALM) | Q3 2007 | 53% |
BlackBerry (BB) | Q3 2007 | 46.38% |
KBR (KBR) | Q3 2007 | 45.92% |
Oceaneering International (OII) | Q3 2007 | 44% |
Amicus Therapeutics (FOLD) | Q3 2007 | 43.19% |
Seabridge Gold (SA) | Q3 2007 | 42.56% |
LKQ (LKQ) | Q3 2007 | 40.08% |
NOV (NOV) | Q3 2007 | 38.61% |
Argan (AGX) | Q3 2007 | 37.93% |
Mosaic (MOS) | Q3 2007 | 37.16% |
Golar LNG (GLNG) | Q3 2007 | 36.44% |
Companhia Siderurgica Nacional ADR (SID) | Q3 2007 | 35.09% |
Masimo (MASI) | Q3 2007 | 35.05% |
Synaptics (SYNA) | Q3 2007 | 33.37% |
CECO Environmental (CECO) | Q3 2007 | 33.22% |
Option Care Health (OPCH) | Q3 2007 | 32.92% |
FTI Consulting (FCN) | Q3 2007 | 31.39% |
Applied Digital (APLD) | Q3 2007 | 31.16% |
Leonardo DRS, Inc Common Stock (DRS) | Q3 2007 | 30.72% |
Onto Innovation (ONTO) | Q3 2007 | 30.38% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
